Enzymatic and non-enzymatic antioxidative effects of folic acid and its reduced derivates

Sub-Cellular Biochemistry

Volumn 56, Issue , 2012, Pages 131-161

  Stanger, Olaf ^a   Wonisch, Willibald ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Endothelial NO synthase (eNOS); Folic acid; Glutathione peroxidase; Peroxynitrite; Superoxide anion

Indexed keywords

ANTIOXIDANT; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOLIC ACID; HOMOCYSTEINE;

ANIMAL; DRUG EFFECT; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIOXIDANTS; FOLIC ACID; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84868196854     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-007-2199-9_8     Document Type: Article

References (123)

1. Anguera, MC, Suh, JR (2003) Methylenetetrahydrofolate synthetase regulates folate turnover and accumulation. J Biol Chem 278: pp. 29856-29862
2. Anthony, AC (1996) Folate receptors. Annu Rev Nutr 16: pp. 501-521
3. Antoniades, C, Shirodaria, C, Leeson, P, Baarholm, OA, Assche, T, Cunnington, C, Pillai, R, Ratnatunga, C, Tousoulis, D, Stefanadis, C, Refsum, H, Channon, KM (2009) MTHFR 677C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119: pp. 2507-2515
4. Antoniades, C, Shirodaria, C, Warrick, N, Cai, S, Bono, J, Lee, J, Leeson, P, Neubauer, S, Ratnatunga, C, Pillai, R, Refsum, H, Channon, KM(2006) 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels. Circulation 114: pp. 1193-1201
5. Austin, RC, Sood, SK, Dorward, AM, Singh, G, Shaughnessy, SG, Pamidi, S, Outinen, PA, Weitz, JI (1998) Homocysteine-dependent alterations in mitochondrial gene expression, function and structure. J Biol Chem 273: pp. 30808-30817
6. Baggott, JE, Tamura, T, Baker, H (2001) Re-evaluation of the metabolism of oral doses of racemic carbon isomers of formyltetrahydrofolate in human subjects. Br J Nutr 85: pp. 653-657
7. Beckman, JS, Koppenol, WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271: pp. C1424-C1437
8. Benzie, IF, Strain, JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analyt Biochem 239: pp. 70-76
9. Blair, JA (1957) Some observations on the oxidative degradation of pteroyl-L-glutamic acid. Biochem J 65: pp. 209-211
10. Boushey, CJ, Beresford, SA, Omenn, GS, Motulsky, AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 274: pp. 1049-1057
11. Bunout, D, Petermann, M, Hirsch, S, Maza, P, Suazo, M, Barrera, G, Kauffman, R (2000) Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls. Nutrition 16: pp. 434-438
12. Campolo, J, Chiara, B, Caruso, R, Maria, R, Sedda, V, Dellanoce, C, Parolini, M, Cighetti, G, Penco, S, Baudo, F, Parodi, O (2006) Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs. normohomocysteinemia. Free Radic Res 40: pp. 929-935
13. Caruso, R, Campolo, J, Sedda, V, Chiara, B, Dellanoce, C, Baudo, F, Tonini, A, Parolini, M, Cighetti, G, Parodi, O (2006) Effect of homocysteine lowering by 5-methyltetrahydrofolate on redox status in hyperhomocysteinemia. J Cardiovasc Pharmacol 47: pp. 549-555
14. Celano, L, Gil, M, Carballal, S, Duran, R, Denicola, A, Banerjee, R, Alvarez, B (2009) Inactivation of cystathionine β-synthase with peroxynitrite. Arch Biochem Biophys Arch Biochem Biophys 491: pp. 96-105
15. Celermajer, DS, Sorensen, K, Ryalls, M, Robinson, J, Thomas, O, Leonard, JV, Deanfield, JE (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 22: pp. 854-858
16. Chambers, JC, McGregor, A, Jean-Marie, J, Obeid, OA, Kooner, JS (1999) Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99: pp. 1156-1160
17. Chang, CM, Yu, CC, Lu, HT, Chou, YF, Huang, RF (2007) Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver. Br J Nutr 97: pp. 855-863
18. Chen, N, Liu, Y, Greiner, CD, Holtzman, JL (2000) Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides. J Lab Clin Med 136: pp. 58-65
19. Chiao, JH, Roy, K, Tolner, B, Yang, CH, Sirotnak, FM (1997) RFC-1 gene expression regulates folate absorption in mouse small intestine. J Biol Chem 272: pp. 11165-11170
20. Chippel, D, Scrimgeour, KG (1970) Oxidative degradation of dihydrofolate and tetrahydrofolate. Can J Biochem 48: pp. 999-1009
21. Coppola, A, D’Angelo, A, Fermo, I, Mazzola, G, Minno, M, Cajani, A, Sala, A, Folco, G, Tremoli, E, Minno, G (2005) Reduced in vivo oxidative stress follwoing 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. Br J Haematol 131: pp. 100-108
22. Crabtree, MJ, Tatham, AL, Hale, AB, Alp, NJ, Channon, KM (2009) Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling. J Biol Chem 284: pp. 28128-28136
23. Darley-Usmar, V, Wiseman, H, Halliwell, B (1995) Nitric oxide and oxygen radicals: A question of balance. FEBS Lett 369: pp. 131-135
24. Das, U (2003) Folic acid says NO to vascular disease. Nutrition 19: pp. 686-692
25. Davi, G, Minno, G, Coppola, A, Andria, G, Cerbone, AM, Madonna, P, Tufano, A, Falco, A, Marchesani, P, Ciabattoni, G, Patrono, C (2001) Oxidative stress and platelet activation in homozygous homocystinuria. Circulation 104: pp. 1124-1128
26. Delfino, VD, Vianna, AC, Mocelin, AJ, Barbosa, DS, Mise, RA, Matsuo, T (2007) Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition 23: pp. 242-247
27. Donnelly, JG (2001) Folic acid. Crit Rev Clin Lab Sci 38: pp. 183-221
28. Doshi, SN, McDowell, IF, Moat, SJ, Payne, N, Durrant, HJ, Lewis, MJ, Goodfellow, J (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105: pp. 22-26
29. Droge, W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82: pp. 47-95
30. Durand, P, Lussier-Cacan, S, Blache, D (1997) Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 11: pp. 1157-1168
31. Faraci, FM, Didion, SP (2004) Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24: pp. 1367-1373
32. Ferrer-Sueta, G, Radi, R (2009) Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. ACS Chem Biol 4: pp. 161-177
33. Fuchs, D, Jaeger, M, Widner, B, Wirleitner, B, Artner-Dworzak, A, Leblhuber, F (2001) Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?. Clin Chem Lab Med 39: pp. 691-694
34. Fukai, T, Folz, RJ, Landmesser, U, Harrison, DG (2002) Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55: pp. 239-249
35. Gao, L, Chalupsky, K, Stefani, E, Cai, H (2009) Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity. J Mol Cell Cardiol 47: pp. 752-760
36. Ghandour, H, Chen, Z, Selhub, J, Rozen, R (2004) Mice deficient in methylenetetrahydrofolate reductase exhibit tissue-specific distribution of folates. J Nutr 134: pp. 2975-2978
37. Gliszczynska-Swiglo, A (2007) Folates as antioxidants. Food Chem 101: pp. 1480-1483
38. Gliszcznska-Swiglo, A, Muzolf, M (2007) PH-dependent radical scavenging activity of folates. J Agric Food Chem 55: pp. 8237-8242
39. Haenen, GR, Bast, A (1983) Protection against lipid peroxidation by a microsomal glutathione-dependent labile factor. FEBS Lett 159: pp. 24-28
40. Handy, DE, Zhang, Y, Loscalzo, J (2005) Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J Biol Chem 280: pp. 15518-15525
41. Hasdai, D, Gibbons, RJ, Holmes, DR, Higano, ST, Lerman, A (1997) Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96: pp. 3390-3395
42. Heales, SJ, Blair, JA, Meinschad, C, Ziegler, I (1988) Inhibition of monocyte luminol-dependent chemiluminescence by tetrahydrobiopterin, and the free radical oxidation of tetrahydrobiopterin, dihydrobiopterin and dihydroneopterin. Cell Biochem Funct 6: pp. 191-195
43. Heinecke, JW, Kawamura, M, Suzuki, L, Chait, A (1993) Oxidation of low-density lipoprotein by thiols: superoxide-dependent and –independent mechanisms. J Lipid Res 34: pp. 2051-2061
44. Heller, R, Unbehaun, A, Schellenberg, B, Mayer, B, Werner-Felmayer, G, Werner, ER (2001) L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276: pp. 40-47
45. Higashi-Okai, K, Nagino, H, Yamada, K, Okai, Y (2007) Antioxidant and prooxidant activities of B group vitamins in lipid peroxidation. J UOEH 28: pp. 359-368
46. Hirsch, S, Ronco, AM, Vasquez, M, Maza, MP, Garrido, A, Barrera, G, Gattas, V, Glasinovic, A, Leiva, L, Bunout, D (2004) Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress. Nutrition 134: pp. 1832-1835
47. Huang, A, Vita, JA, Venema, RC, Keaney, JF (2000) Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275: pp. 17399-17406
48. Huang, RF, Hsu, YC, Lin, HL, Yang, FL (2001) Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr 131: pp. 33-38
49. Hyndman, ME, Verma, S, Rosenfeld, RJ, Anderson, TJ, Parsons, HG (2002) Interactions of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 282: pp. 2167-2172
50. Joshi, R, Adhikari, S, Patro, BS, Chattopadhyay, S, Mukherjee, T (2001) Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Rad Biol Med 30: pp. 1390-1399
51. Kathy, KW, Au-Yeung, KW, Woo, CW, Sung, FL, Yip, JC, Siow, YL (2004) Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress. Circ Res 94: pp. 28-36
52. Kuzkaya, N, Weissmann, N, Harrison, DG, Dikalov, S (2003) Interaction of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: pp. 22546-22554
53. Lindschinger, M, Nadlinger, K, Adelwöhrer, N, Holweg, K, Wögerbauer, M, Birkmayer, J, Smolle, KH, Wonisch, W (2004) Oxidative stress: potential of distinct peroxide determination systems. Clin Chem Lab Med 42: pp. 907-914
54. Loscalzo, J (1996) The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98: pp. 5-7
55. Luhrs, CA, Slomiany, BL (1989) A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail. J Biol Chem 264: pp. 21446-21449
56. Lulock, MD, Proestnall, M, Daskalakis, I, Schorah, CJ, Wild, J, Levene, MI (1995) Nonenzymatic degradation and salvage of dietary folate: physicochemical factors likely to influence bioavailibility. Biochem Mol Med 55: pp. 43-53
57. Mayer, B, Schumacher, M, Brandstätter, H, Wagner, FS, Hermetter, A (2001) High-throughput fluorescence screening of antioxidative capacity in human serum. Anal Biochem 297: pp. 144-153
58. Mayer, O, Simon, J, Rosolova, H, Hromadka, M, Subrt, I, Vobrubova, I (2002) The effects of folate supplementation on some coagulation parameters and oxidative status surrogates. Eur J Clin Pharmacol 58: pp. 1-5
59. McCaddon, A, Regland, B, Hudson, P, Davies, G (2002) Functional vitamin (B)12 deficiency and Alzheimer disease. Neurology 58: pp. 1395-1939
60. McCarthy, MF, Barroso-Aranda, J, Contreras, F (2009) High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals. Clinical potential in inflammatory disorders. Med Hypothesis 73: pp. 824-834
61. McEneny, J, Couston, C, McKibben, B, Young, IS, Woodside, JV (2007) Folate: in vitro and in vivo effects on VLDL and LDL oxidation. Int J Vitam Nutr Res 77: pp. 66-72
62. Miura, H, Bosnjak, JJ, Ning, G, Saito, T, Miura, M, Gutterman, DD (2003) Role of hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 92: pp. e31-e40
63. Moens, AL, Claeys, M, Wuytis, FL (2004) Folic acid reduces myocardial ischemia and reperfusion injury by influencing the NO pathway: an in vitro and in vivo study. Circulation 110: pp. III-50
64. Mosharov, E, Cranford, MR, Banerjee, R (2000) The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the trassulfuration pathway and its regulation by redox changes. Biochemistry 39: pp. 13005-13011
65. Mudd, SH, Skovby, F, Levy, HL, Pettigrew, KR, Wilcken, B, Pyeritz, R, Andria, G, Boers, GH, Bromberg, IL, Cerone, R (1985) The natural history of homocystinuria due to cystathionine-β-synthase deficiency. Am J Hum Genet 37: pp. 1-31
66. Murr, C, Baier-Bitterlich, G, Fuchs, D, Werner, ER, Esterbauer, H, Pfleiderer, W, Wachter, H (1996) Effects of neopterin-derivatives on H2O2-induced luminol chemiluminescence: mechanistic aspects. Free Radic Biol Med 21: pp. 449-456
67. Nakamura, M, Nagayoshi, R, Ijiri, K, Nakashima-Matsushita, N, Takeuchi, T, Matsuyama, T (2002) Nitration and chlorination of folic acid by peroxynitrite and hypochlorous acid, and the selective binding of 10-nitro-folate to folate receptor beta. Biochem Biophys Res Comm 297: pp. 1238-1244
68. Odin E, Carlsson G, Frosing R, Gustavsson B, Spears CP, Larsson PA (1998) Chemical stability and human plasma pharmacokinetics of reduced folates. Cancer Invest 447–455
69. Pancharuniti, N, Lewis, CA, Sauberlich, HE, Perkins, LL, Go, RC, Alvarez, JO, Macaluso, M, Acton, RT, Copeland, RB, Cousins, AL (1994) Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59: pp. 940-948
70. Patro, BS, Adhikari, S, Mukherjee, T, Chattopadhyay, S (2005) Possible role of hydroxyl radicals in the oxidative degradation of folic acid. Bioorg Med Chem Lett 15: pp. 67-71
71. Patrono, C, Fitzgerald, GA (1997) Isoprsotanes: potential markers of oxidant stress in atherothrombotic diseae. Arterioscler Thromb Vasc Biol 17: pp. 2309-2315
72. Prasad, PD, Ramamoorthy, S, Moe, AJ, Smith, CH, Leibach, FH, Ganapathy, V (1994) Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim Biophys Acta 1223: pp. 71-75
73. Pullin, CH, Bonham, JR, McDowell, IF, Lee, PJ, Powers, HJ, Wilson, JF, Lewis, MJ, Moat, SJ (2002) Vitamin C therapy ameliorates vascular endothelial dysfunction in treated patients with homocystinuria. J Inherit Metab Dis 25: pp. 107-118
74. Rice-Evans, CA, Miller, NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234: pp. 279-293
75. Rimm, EB, Willett, WC, Hu, FB (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc 279: pp. 359-364
76. Rogers, EJ, Chen, SS, Chan, A (2007) Folate deficiency and plasma homocysteine during increased oxidative stress. N Engl J Med 357: pp. 421-422
77. Robinson, K, Arheart, K, Refsum, H, Brattstrom, L, Boers, G, Ueland, P, Rubba, P, Palma-Reis, R, Meleady, R, Daly, L (1998) Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease: European COMAC Group. Circulation 97: pp. 437-443
78. Rzek, BM, Haenen, GR, Vijgh, WJ, Bast, A (2003) Tetrahydrofolate and 5-methyltetrahydrofolate are folates with high antioxidant activity. Identification of the antioxidant pharmacophore. FEBS Lett 555: pp. 601-605
79. Said, HM, Nguyen, TT, Dyer, DL, Cowan, KH, Rubin, SA (1996) Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA. Biochim Biophys Acta 1281: pp. 164-172
80. Schachinger, V, Britten, MB, Zeiher, AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101: pp. 1899-1906
81. Schwartz, SM, Siscovick, DS, Malinow, MR, Rosendaal, FR, Beverly, RK, Hess, DL, Psaty, BM, Longstreth, WT, Koepsell, TD, Raghunathan, TE (1997) Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 96: pp. 412-417
82. Scott, JM, Weir, DG (1981) The methyl folate trap. Lancet 8242: pp. 838-840
83. Shane, B (1989) Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 45: pp. 263-335
84. Shaw, S, Jayatilleke, E, Herbert, V, Colman, N (1989) Cleavage of folates during ethanol metabolism. Biochem J 257: pp. 277-280
85. Shidfar, F, Homayounfar, R, Fereshtehnejad, SM, Kalani, A (2009) Effect of folate supplementation on serum homocysteine and plasma antioxidant capacity in hyüercholesterolemic adults under lovastatin treatment: a double-blind randomized controlles clinical trial. Arch Med Red 40: pp. 380-386
86. Sies, H, Sharov, VS, Klotz, LO, Briviba, K (1997) Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 272: pp. 27812-27817
87. Sirotnak, FM, Tolner, B (1999) Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 19: pp. 91-122
88. Spijkerman, AM, Smulders, YM, Kostense, PJ, Henry, RM, Becker, A, Teerlink, T, Jakobs, C, Dekker, JM, Nijpels, G, Heine, RJ, Bouter, LM, Stehouwer, CD (2005) S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study. Arterioscler Thromb Vasc Biol 25: pp. 778-784
89. Sprecher, E, Bergman, R, Sprecher, H, Maor, G, Reiter, I, Krivoy, N, Drori, S, Assaraf, YG, Friedman-Birnbaum, R (1998) Reduced folate carrier (RFC-1) gene expression in normal and psoriatic skin. Arch Dermatol Res 290: pp. 656-660
90. Stanger, O (2002) Physiology of folic acid in health and disease. Curr Drug Metab 3: pp. 211-223
91. Stanger, O, Fowler, B, Pietrzik, K, Huemer, M, Haschke-Becher, E, Semmler, A, Lorenzl, S, Linnebank, M (2009) Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother 9: pp. 1393-1412
92. Stanger, O, Herrmann, W, Pietrzik, K, Fowler, B, Geisel, J, Dierkes, J, Weger, M (2003) consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41: pp. 1392-1403
93. Stanger, O, Semmelrock, HJ, Wonisch, W, Bös, U, Pabst, E, Wascher, TC (2002) Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 303: pp. 158-162
94. Stanger, O, Weger, M (2003) Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med 41: pp. 1444-1454
95. Stanger, O, Weger, M, Renner, W, Konetschny, R (2001) Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease. Clin Chem Lab Med 39: pp. 725-733
96. Steinberg, SE, Campbell, CL, Hillmann, RS (1979) Kinetics of the normal folate enterohepatic cycle. J Clin Invest 64: pp. 83-88
97. Stocker, P, Lesgards, JF, Vidal, N, Chalier, F, Prost, M (2003) ESR study of a biological assay on whole blood: antioxidant efficiency of various vitamins. Biochim Biophys Acta 1621: pp. 1-8
98. Stralin, P, Karlsson, K, Johansson, BO, Marklund, SL (1996) The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15: pp. 2031-2036
99. Stroes, ES, Faassen, EE, Yo, M, Martasek, P, Govers, R, Rabelink, TJ (2000) Folic acid recerts dysfunction of endothelial nitric oxide synthase. Circ Res 86: pp. 1129-1134
100. Suwaidi, JA, Hamasaki, S, Higano, ST, Nishimura, RA, Holmes, DR, Lerman, A (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: pp. 948-954
101. Tatzber, F, Griebenow, S, Wonisch, W, Winkler, R (2002) Dual method for the determination of peroxidase activity and total peroxides – iodide leads to a significant increase of peroxidase activity in human sera. Anal Biochem 316: pp. 147-153
102. Tchantchou F (2006) Homocysteine increase folate oxidative brain homocysteine metabolism and various consequences of folate deficiency. J Alzheimers Dis 421–427
103. Ungvari, Z, Csiszar, A, Bagi, Z, Koller, A (2002) Impaired NO-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation. Am J Pathol 161: pp. 145-153
104. Ungvari, Z, Csiszar, A, Edwards, JG, Kaminski, PM, Wolin, MS, Kaley, G, Koller, A (2003) Increased superoxide production in coronary arteries in hyperhomocysteinemia. Role of tumor necrosis factor-α, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 23: pp. 418-424
105. Upchurch, GR, Welch, GN, Fabian, AJ, Freedman, JE, Johnson, JL, Keaney, JF, Loscalzo, J (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272: pp. 17012-17017
106. Usui, M, Matsuoka, H, Miyazaki, H, Ueda, S, Okuda, S, Imaizumi, T (1999) Endothelial dysfunction by acute hyperhomocyst(e)inemia: restoration by folic acid. Clin Sci 96: pp. 235-239
107. Verhaar, MC, Stroes, E, Rabelink, TJ (2002) Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol 22: pp. 6-13
108. Verhaar, MC, Wever, RM, Kastelein, JJ, Dam, T, Koomans, HA, Rabelink, TJ (1998) 5-methyltetrahyrofolate, the active form of folic acid, improves endothelial dysfunction in familial hypercholesterolemia. Circulation 97: pp. 237-241
109. Verhoef, P, Stampfer, MJ, Buring, JE, Gaziano, JM, Allen, RH, Stabler, SP, Reynolds, RD, Kok, FJ, Hennekens, CH, Willett, WC (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 143: pp. 845-859
110. Verlinde, PH, Oey, I, Hendrickx, ME, Loey, AM, Temme, EH (2008) L-ascorbic acid improves the serum folate response to an oraal dose of [6S]-5-methyltetrahydrofolic acid in healthy men. Eur J Clin Nutr 62: pp. 1224-1230
111. Voutilainen, S, Morrow, JD, Roberts, LJ, Alfthan, G, Alho, H, Nyyssönen, K, Salonen, JT (1999) Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19: pp. 1263-1266
112. Weiss, N, Heydrick, S, Zhang, YY, Bierl, C, Loscalzo, J (2002) Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler Thromb Vasc Biol 22: pp. 34-41
113. Weiss, N, Zhang, YY, Heydrick, S, Bierl, C, Loscalzo, J (2001) Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci USA 98: pp. 12503-12508
114. Widner, B, Enzinger, C, Laich, A, Wirleitner, B, Fuchs, D (2002) Hyperhomocysteinemia, pteridines and oxidative stress. Curr Drug Metab 3: pp. 225-232
115. Widner, B, Fuchs, D, Leblhuber, F, Sperner-Unterweger, B (2001) Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress?. J Neurol Neurosurg Psychiatr 70: pp. 419
116. Wilcken, DE, Wang, XL, Adachi, T, Hara, H, Duarte, N, Gren, K, Wilcken, B (2000) Relationship between homocysteine and superoxide dismutase in homocystinuria. Possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol 20: pp. 1199-1202
117. Wilcken, DE, Wilcken, B (1997) The natural history of vascular disease in homocystinuria and effects of treatment. J Inherit Metab Dis 20: pp. 295-300
118. Wilmink, HW, Stroes, ES, Erkelens, WD, Gerritsen, WB, Wever, R, Banga, JD, Rabelink, JD (2000) Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 20: pp. 185-188
119. Xu, J, Wu, Y, Song, P, Zhang, M, Wang, S, Zou, MH (2007) Proteasome-dependent degradation of guanosine 5′- triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116: pp. 944-953
120. Yamamoto, M, Hara, H, Adachi, T (2000) Effect of homocysteine on the binding of extracellular-superoxide dismutase on the endothelial cell surface. FEBS Lett 486: pp. 159-162
121. Yap, S, Boers, GH, Wilcken, B, Wilcken, DE, Brenton, DP, Lee, PJ, Walter, JH, Howard, PM, Naughten, ER (2001) Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol 21: pp. 2080-2085
122. Yap, S, Naughten, ER, Wilcken, B, Wilcken, DE, Boers, GH (2000) Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. Semin Thromb Hemost 26: pp. 335-340
123. Zeiher, AM, Krause, T, Schachinger, V, Minners, J, Moser, E (1995) Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise induced myocardial ischemia. Circulation 91: pp. 2345-2352